| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $12.74M | $18.02M | $25.06M | $36.43M | $36.83M |
| SG&A | $8.10M | $4.99M | $6.06M | $7.29M | $8.53M |
| Operating Income | -$20.11M | -$22.81M | -$32.78M | -$39.12M | -$47.91M |
| Interest Expense | $12.65M | – | – | – | – |
| Tax Expense | -$1.17M | -$3.45M | -$4.40M | -$6.43M | -$7.27M |
| Net Income | -$29.35M | -$19.00M | -$27.63M | -$32.02M | -$40.53M |
| EPS (basic) | 0.0000 | -0.2600 | -0.5300 | – | – |
| EPS (diluted) | 0.0000 | -0.2600 | -0.5300 | – | – |
| Shares (diluted) | – | – | – | – | – |